IRIS Accounts Production v24.3.0.553 07250140 Board of Directors 1.6.23 31.5.24 31.5.24 false true false false true false Ordinary 1.00000 A Ordinary 1.00000 B Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh072501402023-05-31072501402024-05-31072501402023-06-012024-05-31072501402022-05-31072501402022-06-012023-05-31072501402023-05-3107250140ns15:EnglandWales2023-06-012024-05-3107250140ns14:PoundSterling2023-06-012024-05-3107250140ns10:Director12023-06-012024-05-3107250140ns10:PrivateLimitedCompanyLtd2023-06-012024-05-3107250140ns10:SmallEntities2023-06-012024-05-3107250140ns10:AuditExempt-NoAccountantsReport2023-06-012024-05-3107250140ns10:SmallCompaniesRegimeForDirectorsReport2023-06-012024-05-3107250140ns10:SmallCompaniesRegimeForAccounts2023-06-012024-05-3107250140ns10:FullAccounts2023-06-012024-05-3107250140ns10:OrdinaryShareClass12023-06-012024-05-3107250140ns10:OrdinaryShareClass22023-06-012024-05-3107250140ns10:OrdinaryShareClass32023-06-012024-05-3107250140ns10:Director22023-06-012024-05-3107250140ns10:Director32023-06-012024-05-3107250140ns10:Director42023-06-012024-05-3107250140ns10:RegisteredOffice2023-06-012024-05-3107250140ns5:CurrentFinancialInstruments2024-05-3107250140ns5:CurrentFinancialInstruments2023-05-3107250140ns5:ShareCapital2024-05-3107250140ns5:ShareCapital2023-05-3107250140ns5:RetainedEarningsAccumulatedLosses2024-05-3107250140ns5:RetainedEarningsAccumulatedLosses2023-05-3107250140ns5:PlantMachinery2023-06-012024-05-3107250140ns5:MotorVehicles2023-06-012024-05-3107250140ns5:ComputerEquipment2023-06-012024-05-3107250140ns5:PlantMachinery2023-05-3107250140ns5:MotorVehicles2023-05-3107250140ns5:ComputerEquipment2023-05-3107250140ns5:PlantMachinery2024-05-3107250140ns5:MotorVehicles2024-05-3107250140ns5:ComputerEquipment2024-05-3107250140ns5:PlantMachinery2023-05-3107250140ns5:MotorVehicles2023-05-3107250140ns5:ComputerEquipment2023-05-3107250140ns5:WithinOneYearns5:CurrentFinancialInstruments2024-05-3107250140ns5:WithinOneYearns5:CurrentFinancialInstruments2023-05-3107250140ns5:DeferredTaxation2023-05-3107250140ns5:DeferredTaxation2023-06-012024-05-3107250140ns5:DeferredTaxation2024-05-3107250140ns10:OrdinaryShareClass12024-05-3107250140ns10:OrdinaryShareClass22024-05-3107250140ns10:OrdinaryShareClass32024-05-31
REGISTERED NUMBER: 07250140 (England and Wales)















Financial Statements for the Year Ended 31 May 2024

for

Adini Dermatology Limited

Adini Dermatology Limited (Registered number: 07250140)

Contents of the Financial Statements
for the Year Ended 31 May 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Adini Dermatology Limited

Company Information
for the Year Ended 31 May 2024







DIRECTORS: J Bhat
A Bhat
A Bhat
R J Bhat





REGISTERED OFFICE: Suites 5 & 6 The Printworks
Hey Road
Barrow
Clitheroe
Lancashire
BB7 9WB





REGISTERED NUMBER: 07250140 (England and Wales)





ACCOUNTANTS: Bennett Kirkhope Smith
Chartered Certified Accountants
Suites 5 & 6 The Printworks
Hey Road
Barrow
Clitheroe
Lancashire
BB7 9WB

Adini Dermatology Limited (Registered number: 07250140)

Balance Sheet
31 May 2024

31.5.24 31.5.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 71,801 18,885

CURRENT ASSETS
Debtors 5 22,307 74,005
Investments 6 176,560 170,136
Cash at bank and in hand 815,461 805,365
1,014,328 1,049,506
CREDITORS
Amounts falling due within one year 7 67,154 143,603
NET CURRENT ASSETS 947,174 905,903
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,018,975

924,788

PROVISIONS FOR LIABILITIES 8 4,933 4,721
NET ASSETS 1,014,042 920,067

CAPITAL AND RESERVES
Called up share capital 9 1,100 1,100
Retained earnings 1,012,942 918,967
SHAREHOLDERS' FUNDS 1,014,042 920,067

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Adini Dermatology Limited (Registered number: 07250140)

Balance Sheet - continued
31 May 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4 October 2024 and were signed on its behalf by:





J Bhat - Director


Adini Dermatology Limited (Registered number: 07250140)

Notes to the Financial Statements
for the Year Ended 31 May 2024


1. STATUTORY INFORMATION

Adini Dermatology Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Medical equipment - 20% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2023 - 4 ) .

Adini Dermatology Limited (Registered number: 07250140)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2024


4. TANGIBLE FIXED ASSETS
Medical Motor Computer
equipment vehicles equipment Totals
£    £    £    £   
COST
At 1 June 2023 1,271 50,740 4,992 57,003
Additions - 83,497 1,902 85,399
Disposals - (50,740 ) - (50,740 )
At 31 May 2024 1,271 83,497 6,894 91,662
DEPRECIATION
At 1 June 2023 1,271 33,348 3,499 38,118
Charge for year - 13,916 1,175 15,091
Eliminated on disposal - (33,348 ) - (33,348 )
At 31 May 2024 1,271 13,916 4,674 19,861
NET BOOK VALUE
At 31 May 2024 - 69,581 2,220 71,801
At 31 May 2023 - 17,392 1,493 18,885

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.24 31.5.23
£    £   
Trade debtors 18,027 13,678
Other debtors - 3,000
Tax 3,675 56,875
Prepayments 605 452
22,307 74,005

6. CURRENT ASSET INVESTMENTS
31.5.24 31.5.23
£    £   
Listed investments 106,240 99,816
Unlisted investments 70,320 70,320
176,560 170,136
Market value of listed investments at 31 May 2024 - £ 171,511 (2023 - £ 165,778 ).

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.24 31.5.23
£    £   
Trade creditors 2,145 2,019
Corporation tax 56,894 44,254
Social security and other taxes 1,304 -
Directors' current accounts 3,966 94,169
Accrued expenses 2,845 3,161
67,154 143,603

Adini Dermatology Limited (Registered number: 07250140)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2024


8. PROVISIONS FOR LIABILITIES
31.5.24 31.5.23
£    £   
Deferred tax 4,933 4,721

Deferred
tax
£   
Balance at 1 June 2023 4,721
Charge to Statement of Income and Retained Earnings during year 212
Balance at 31 May 2024 4,933

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.5.24 31.5.23
value: £    £   
1,000 Ordinary £1 1,000 1,000
50 A Ordinary £1 50 50
50 B Ordinary £1 50 50
1,100 1,100

10. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is J Bhat.